Amicogen Inc (092040) — Cash Flow-to-Debt Ratio
Amicogen Inc (092040) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of ₩-3.58 Billion could theoretically repay 0% of its total liabilities (₩80.33 Billion) in one year. See Amicogen Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Amicogen Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Amicogen Inc across 12 annual periods. For the full cash flow conversion analysis, see Amicogen Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Amicogen Inc (2014–2025)
Year-by-year debt coverage analysis for Amicogen Inc. Check 092040 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | ₩-24.42 Billion | ₩136.00 Billion | ▼ -131.3% |
| 2024 | -0.08x | ₩-13.34 Billion | ₩171.73 Billion | ▼ -322.9% |
| 2023 | 0.03x | ₩8.64 Billion | ₩248.12 Billion | ▲ +146.3% |
| 2022 | -0.08x | ₩-22.41 Billion | ₩297.86 Billion | ▼ -309.8% |
| 2021 | 0.04x | ₩8.07 Billion | ₩225.06 Billion | ▼ -47.2% |
| 2020 | 0.07x | ₩8.87 Billion | ₩130.43 Billion | ▼ -7.4% |
| 2019 | 0.07x | ₩8.76 Billion | ₩119.35 Billion | ▲ +168.6% |
| 2018 | 0.03x | ₩2.84 Billion | ₩103.93 Billion | ▼ -82.9% |
| 2017 | 0.16x | ₩11.88 Billion | ₩74.32 Billion | ▼ -8.1% |
| 2016 | 0.17x | ₩11.28 Billion | ₩64.79 Billion | ▲ +9.6% |
| 2015 | 0.16x | ₩12.34 Billion | ₩77.74 Billion | ▼ -84.4% |
| 2014 | 1.02x | ₩4.43 Billion | ₩4.35 Billion | — |